Medicinal Chemistry
-
Novel compounds open new research avenues for Alzheimer’s disease therapeutics
Two new compounds developed at the Vanderbilt University Warren Center for Neuroscience Drug Discovery will enable research into a protein family with ties to Alzheimer’s disease, setting the stage for the development of a different kind of therapeutic than is currently available. Read MoreFeb. 24, 2026
-
Vanderbilt research looks to smooth out bumps in medicinal chemistry processes
Vanderbilt researchers probe the mysteries of an enzyme that could be used as a tool in basic research and medicinal chemistry. Read MoreSep. 23, 2025
-
New drug candidates targeting blood clots developed through computer-aided drug design
Using computer-aided drug design, the labs of Heidi Hamm, Jens Meiler, and Craig Lindsley generated a novel series of biologically active compounds that can serve as a basis for anti–blood clot preventative drugs. Read MoreJun. 6, 2024